ARA-290 is a non-erythropoietic erythropoietin-derived peptide used to study the innate repair receptor. Research commonly focuses on neuroinflammation, nerve-fiber recovery, endothelial repair, and tissue-protective signaling without the erythropoietic activity of full EPO.

What this formula features: Selective activation of the EPOR/CD131 innate repair receptor is the central research feature. Published work has examined neuropathic signaling, corneal nerve-fiber density, endothelial progenitor-cell migration, inflammatory responses, and tissue-protective pathways.

Typical research readouts: Typical endpoints include inflammatory cytokines, nerve-fiber density, sensory or allodynia measures in animal models, endothelial-cell proliferation/migration, oxidative-stress resistance, and repair-pathway signaling. Effects are highly model- and injury-context dependent.

This product is strictly for research purposes only. Not approved for human or animal use.